Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Asian J Endosc Surg ; 17(3): e13310, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38623612

RESUMO

Gastrointestinal stromal tumors surrounding the esophagogastric junction are often challenging to resect, with no consensus regarding the optimal surgical technique. Here in, we present a case of concurrent gastric cancer in the antrum and gastrointestinal stromal tumors adjacent to the esophagogastric junction. The patient underwent simultaneous distal gastrectomy and local resection assisted by a surgical robot, avoiding the need for total gastrectomy. The utilization of robot-assisted surgery has become an increasingly popular technique, holding promise for simplifying complex surgical procedures across diverse medical settings.


Assuntos
Tumores do Estroma Gastrointestinal , Laparoscopia , Robótica , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/cirurgia , Neoplasias Gástricas/patologia , Tumores do Estroma Gastrointestinal/cirurgia , Tumores do Estroma Gastrointestinal/patologia , Laparoscopia/métodos , Gastrectomia/métodos , Estudos Retrospectivos
2.
Gan To Kagaku Ryoho ; 51(1): 59-61, 2024 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-38247093

RESUMO

Therapy with an aromatase inhibitor(AI)was initiated in a 91-year-old female patient after she had been diagnosed with breast cancer. One week after taking the medicine, she experienced multiple joint pain in her upper extremities. Finally, she was diagnosed with rheumatoid arthritis(RA). Joint pains are frequently recognized as adverse events associated with the administration of an AI; however, the presentation of RA is rare. It has been shown that AI reinforces the activity of osteoclasts. On the other hand, the association between AI and the pathogenesis of RA remains unclear.


Assuntos
Artrite Reumatoide , Neoplasias da Mama , Humanos , Feminino , Idoso de 80 Anos ou mais , Inibidores da Aromatase/efeitos adversos , Neoplasias da Mama/tratamento farmacológico , Artrite Reumatoide/tratamento farmacológico , Artralgia , Menopausa
3.
J Surg Case Rep ; 2023(9): rjad536, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-37781046

RESUMO

Castleman disease (CD) is a rare lymphoproliferative disease. Hyaline-vascular type unicentric CD has a good prognosis if completely resected during surgery. However, follicular dendritic cell proliferative lesions have the potential for recurrence and metastasis. A 22-year-old man was referred to our hospital with the chief complaint of nausea and vomiting. These symptoms were caused by a right mesocolonic tumor pushing the duodenum. The patient underwent laparoscopic tumorectomy and complete surgical excision. The postoperative course was uneventful, with no complications. Pathological examination confirmed that the tumor was an enlarged lymph node, typical of hyaline vascular-type CD; however, follicular dendritic cell proliferative lesions were noted. We report a rare case of hyaline-vascular-type CD with follicular dendritic cell proliferative lesions associated with malignancy, as limited case reports exist on this particular disease.

4.
Gan To Kagaku Ryoho ; 43(5): 633-5, 2016 May.
Artigo em Japonês | MEDLINE | ID: mdl-27210098

RESUMO

A 54-year-old woman diagnosed with sigmoid colon cancer and multiple liver metastases underwent sigmoidectomy, partial hepatectomy, and RFA in September 2009. Because of postoperative liver and lung recurrence, 5 regimens with combinations of L-OHP/CPT-11 plus anti-VEGF antibody/anti-EGFR antibody was performed. Following these treatments, she underwent hepatic arterial infusion therapy with UFT/Krestin for progressive liver metastases. Starting in November 2014, regorafenib was administered, with an immediate decrease in tumor marker levels; tumor reduction demonstrated enhanced effect against liver metastases. After 8 months of administration, we stopped regorafenib and changed to TAS-102 due to diarrhea and eating disorders. However, TAS-102 was not effective; there were significant increases in tumor markers, liver function tests, and tumor size on computed tomography, and worsening of abdominal pain. After re-administration of regorafenib, a rapid decrease in tumor marker levels and improvement of liver dysfunction and abdominal pain were observed. Re-administration continued for 8 months until best supportive care was instituted. In cases with observed therapeutic effect of regorafenib, long-term or re-administration is possible, with extension of the prognosis depending on the adjustment, and without size reduction of metastatic tumors.


Assuntos
Compostos de Fenilureia/uso terapêutico , Piridinas/uso terapêutico , Neoplasias do Colo Sigmoide/tratamento farmacológico , Colectomia , Evolução Fatal , Feminino , Hepatectomia , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/secundário , Pessoa de Meia-Idade , Neoplasias do Colo Sigmoide/patologia , Neoplasias do Colo Sigmoide/cirurgia , Fatores de Tempo
5.
Kyobu Geka ; 66(4): 279-83, 2013 Apr.
Artigo em Japonês | MEDLINE | ID: mdl-23575178

RESUMO

For aging, people having malignant disease are increasing. And surgical resection is an important part in the treatment of pulmonary metastasis from colorectal cancer. We analyzed the treatment outcome and prognostic factors affecting survival in our subset of patients. We have experienced 64 operations of metastatic lung tumors from colorectal cancer for 23 years since January 1988. Various factors affecting prognosis are studied based on 5-year survival in this report. Overall 5-year survival rate was 38.7%. The disease-free intervals more than 2 years, a solitary metastatic pulmonary lesion and the serum level of prethoracotomy carcinoembryonic antigen (CEA) were significantly affecting factors on the prognosis. Furthermore, sequential study for 23 years couldn't demonstrate the prognostic improvement by the advance of the thoracoscopic technology or the development of the new anti-cancer drugs, though the treatment of patients with pulmonary metastases from colorectal cancer continues to evolve. The role of pulmonary metastasectomy is very important to reduce the volume of metastatic lesions for the better prognosis.


Assuntos
Neoplasias Colorretais/patologia , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígeno Carcinoembrionário/sangue , Feminino , Humanos , Neoplasias Pulmonares/mortalidade , Masculino , Metastasectomia , Pessoa de Meia-Idade , Pneumonectomia , Prognóstico , Resultado do Tratamento
6.
Gan To Kagaku Ryoho ; 37(3): 499-501, 2010 Mar.
Artigo em Japonês | MEDLINE | ID: mdl-20332691

RESUMO

A 51-year-old woman, who had undergone mastectomy due to a mucinous carcinoma of her left breast, was diagnosed with solitary liver metastasis 7 months after operation. Systemic chemotherapy consisting of 5 courses of FEC75 (cyclophosphamide 500 mg/m2, epirubicin 75 mg/m2, and 5-FU 500 mg/m2 on 1st day, with 1 course for 21 days) was followed by sequential hormonal therapy with tamoxifen citrate and letrozole. The size of metastatic lesions on CT gradually reduced, and FDG-PET, which was conducted 4 months after initiation of FEC75, showed no viable tumor cells in the target lesion. No recurrence has been seen while taking letrozole. We report this case with some consideration of the literature.


Assuntos
Adenocarcinoma Mucinoso/patologia , Antineoplásicos Hormonais/uso terapêutico , Antineoplásicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/patologia , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/secundário , Nitrilas/uso terapêutico , Tamoxifeno/uso terapêutico , Triazóis/uso terapêutico , Adenocarcinoma Mucinoso/tratamento farmacológico , Adenocarcinoma Mucinoso/cirurgia , Antibióticos Antineoplásicos/administração & dosagem , Antineoplásicos Alquilantes/administração & dosagem , Neoplasias da Mama/cirurgia , Ciclofosfamida/administração & dosagem , Epirubicina/administração & dosagem , Feminino , Fluoruracila/administração & dosagem , Humanos , Letrozol , Mastectomia , Pessoa de Meia-Idade
7.
Gan To Kagaku Ryoho ; 33(6): 825-8, 2006 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-16770106

RESUMO

An 81-year-old man was admitted to our department due to acute ileus. He was diagnosed with sigmoid colon cancer with multiple metastatic lesions in the right lobe of the liver. Two weeks after insertion of an ileus tube, he underwent sigmoidectomy and permanent colostomy. The final diagnosis was stage IV sigmoid colon cancer with metastasis to the omentum. One month after the operation, adjuvant chemotherapy with oral administration of tegafur/uracil compound (UFT) and Leucovorin (LV), and drip venous infusion of irinotecan hydrochloride (CPT-11) was initiated (UFT 300 mg/day for 14 days, LV 75 mg/day for 14 days, CPT-11 90 mg/m(2) on the 1 st day, with 1 course consisting of 21 days). The levels of tumor markers, CA19-9 and CEA, and the size of metastases on CT were reduced remarkably after one and 4 courses of this therapy, respectively. Although the administration was temporarily discontinued due to low-grade nausea, we continued the treatment. Adjuvant chemotherapy with an oral administering agent is favorable for older patients with advanced colorectal cancer to reduce side effects and preserve the quality of life.


Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Hepáticas/secundário , Neoplasias Retais/tratamento farmacológico , Adenocarcinoma/secundário , Adenocarcinoma/cirurgia , Administração Oral , Idoso de 80 Anos ou mais , Camptotecina/administração & dosagem , Camptotecina/análogos & derivados , Colo Sigmoide/cirurgia , Colostomia , Esquema de Medicação , Combinação de Medicamentos , Humanos , Infusões Intra-Arteriais , Irinotecano , Leucovorina/administração & dosagem , Masculino , Omento/patologia , Neoplasias Peritoneais/secundário , Neoplasias Retais/patologia , Neoplasias Retais/cirurgia , Indução de Remissão , Tegafur/administração & dosagem , Uracila/administração & dosagem
8.
J Cutan Pathol ; 29(3): 185-9, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11972718

RESUMO

BACKGROUND: Anogenital Paget's disease (PD) may be accompanied by varying degrees of epidermal hyperplasia. The histological changes can be reminiscent of fibroepithelioma of Pinkus. METHODS: We present a case of perianal PD associated with fibroepitheliomatous epidermal hyperplasia in a 76-year-old-man with an underlying rectal mucinous carcinoma. We also carried out a retrospective analysis of 51 biopsies from 49 cases of extramammary PD to see whether particular epidermal changes occur in association with PD in different anatomic locations. RESULTS: A tumor, 3 cm in diameter, was noted in the patient's perianal skin. Histologically, it was composed of anastomosing thin epithelial strands with follicular differentiation. Paget's cells were distributed in the epithelial strands of this tumor as well as in the surrounding epidermis and anal epithelia. In our series of extramammary PD, epidermis was hyperplastic in two of two perianal cases, 26 of 43 genital skin samples, and one of six axillary PD biopsies. The stroma beneath the hyperplastic epidermis tended to be rich in thin collagen fibers and fibroblasts. CONCLUSIONS: Anogenital PD was more frequently associated with epidermal hyperplasia than axillary PD. Fibroepitheliomatous hyperplasia may be induced by the altered stroma associated with PD.


Assuntos
Adenocarcinoma Mucinoso/patologia , Neoplasias do Ânus/patologia , Neoplasias Fibroepiteliais/patologia , Neoplasias Primárias Múltiplas/patologia , Doença de Paget Extramamária/patologia , Adenocarcinoma Mucinoso/cirurgia , Idoso , Neoplasias do Ânus/cirurgia , Humanos , Masculino , Neoplasias Fibroepiteliais/cirurgia , Neoplasias Primárias Múltiplas/cirurgia , Doença de Paget Extramamária/cirurgia , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA